Cold Sores (Herpes Labialis) Prevention and Treatment Protocol
Primary Stack
Core supplements with strongest evidenceCompetes with arginine which is needed for viral replication; may reduce outbreak frequency and duration
Antiviral and wound-healing properties; may speed healing as effectively as acyclovir
Supporting Stack
Additional supplements for enhanced resultsTopical zinc may reduce duration; oral zinc supports immune function
Supporting Studies (1)
Antiviral activity against HSV; topical application may reduce symptoms and healing time
Supporting Studies (1)
Supports immune function; may help prevent outbreaks
Supporting Studies (1)
Bee product with antiviral properties; may speed healing when applied topically
Supporting Studies (1)
May reduce pain and speed healing when applied topically
Supporting Studies (1)
May support immune response against viral infections
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Cold sores (herpes labialis) are caused by herpes simplex virus type 1 (HSV-1), which infects most people in childhood and remains dormant in nerve cells for life. Outbreaks cause painful blisters on or around the lips that typically last 7-10 days. Triggers include stress, sun exposure, illness, fatigue, hormonal changes, and immune suppression. While there's no cure, treatments can shorten outbreaks and reduce frequency.
CRITICAL: For frequent or severe outbreaks (more than 6 per year or lasting >2 weeks), prescription antiviral medications (acyclovir, valacyclovir) are more effective than supplements. These work best when started at the first tingling sensation. Cold sores are contagious - avoid kissing or sharing utensils during outbreaks. See a doctor if sores spread to eyes (herpes keratitis is sight-threatening), if you have a weakened immune system, or if outbreaks are unusually severe or frequent. These supplements may help reduce outbreak frequency and duration but don't replace antivirals for significant disease.
* L-Lysine is the most studied supplement for cold sores. It competes with arginine, an amino acid the virus needs to replicate. Studies show it may reduce the frequency, duration, and severity of outbreaks. Avoid high-arginine foods (nuts, chocolate, seeds) during outbreaks.
* Honey (Topical) has antiviral and wound-healing properties. Clinical trials show medical-grade honey (like Manuka) applied to cold sores can speed healing comparably to acyclovir cream.
* Zinc applied topically can reduce duration of cold sores. Oral zinc supports immune function.
* Lemon Balm (Melissa officinalis) has demonstrated antiviral activity against HSV. Topical cream applied early can reduce symptoms and healing time.
* Vitamin C supports immune function and may help reduce outbreak frequency.
* Propolis (bee product) has antiviral properties and may speed healing when applied topically.
* Vitamin E applied topically may reduce pain and promote healing.
* Echinacea may support the immune response against viral infections.
Expected timeline: Topical treatments should be started at first tingle for best results. Lysine prevention requires consistent daily use. Typical cold sore duration is 7-10 days; treatments may reduce this by 1-3 days.
Clinical Perspective
Herpes labialis: recurrent infection caused by HSV-1 (occasionally HSV-2). Primary infection often in childhood (may be asymptomatic); virus establishes latency in trigeminal ganglion. Reactivation triggers: UV exposure, stress, fever, immunosuppression, trauma, menses. Prodrome: tingling, itching, burning (12-24h before vesicles). Lesions: clustered vesicles on erythematous base โ ulcers โ crusting. Healing: 7-10 days. Complications: autoinoculation (eyes - keratitis, genitals), erythema multiforme, eczema herpeticum.
CRITICAL: Antiviral medications most effective. Topical: acyclovir cream, penciclovir cream - start at prodrome. Oral: valacyclovir 2g BID x 1 day, acyclovir 400mg TID x 5 days - more effective than topical. Suppressive therapy for frequent recurrence (โฅ6/year): valacyclovir 500mg daily. Docosanol (Abreva) OTC available. Sun protection (SPF lip balm) reduces UV-triggered outbreaks. Supplements are ADJUNCTIVE for mild/moderate disease or prevention.
* L-Lysine (B-grade): Competes with arginine for HSV replication. Clinical trial: reduced recurrence (PMID: 3115841). Systematic review: modest benefit (PMID: 28509709). 1000mg TID during outbreak; 500-1000mg daily prevention.
* Honey (Topical) (B-grade): Antiviral; wound healing. RCT: comparable to acyclovir (PMID: 15252762). RCT: kanuka honey effective (PMID: 30644969). Apply 3-4x daily.
* Zinc (B-grade): Antiviral; immune support. Clinical trial: topical reduced duration (PMID: 11409943). Topical zinc oxide; oral 15-30mg daily.
* Lemon Balm (B-grade): Antiviral activity against HSV. Meta-analysis: reduced healing time (PMID: 18693101). Apply cream 2-4x daily.
* Vitamin C (C-grade): Immune support. Review: viral infection benefit (PMID: 25144123). 500-1000mg daily.
* Propolis (C-grade): Antiviral; wound healing. RCT: genital herpes benefit (PMID: 10684339). Apply ointment 3-4x daily.
* Vitamin E (C-grade): Topical healing. Case series (PMID: 6283628). Apply to lesion.
* Echinacea (C-grade): Immune support. Review: viral infections (PMID: 24554461). 300-500mg daily.
Biomarker targets: Outbreak frequency, duration, symptom severity, healing time.
Protocol notes: Prevention: sun protection (SPF lip balm), stress management, adequate sleep, avoid triggers. Arginine-rich foods may theoretically worsen outbreaks (nuts, chocolate, seeds) - limited evidence but some avoid during outbreaks. Start treatment at first tingle (prodrome). Topical docosanol (Abreva) OTC option. Ice application may reduce discomfort. Keep lesion clean and dry. Avoid touching (autoinoculation risk) - wash hands frequently. Contagious from prodrome until fully healed. Antiviral suppression for frequent recurrence or immunocompromised. Eye involvement: urgent ophthalmology referral. Eczema patients: risk of eczema herpeticum (widespread HSV - serious). Pregnancy: discuss with OB; neonatal herpes is serious. Resistance to antivirals rare except in immunocompromised. Combination lysine + topical approaches reasonable.